Fareston
toremifene
toremifene
Keep this leaflet. You may need to read it again.
If you have any further questions, ask your doctor or pharmacist.
This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours.
If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4.
What Fareston is and what it is used for
What you need to know before you take Fareston
How to take Fareston
Possible side effects
How to store Fareston
Contents of the pack and other information
Fareston contains the active substance toremifene, an anti-estrogen. Fareston is used for the treatment of a certain type of breast tumour in women who have had their menopause.
if you are allergic to toremifene or any of the other ingredients of this medicine (listed in section 6).
if you have a thickening of the womb lining
if you have severe liver problems
if you were born with or have had any condition which causes certain abnormal changes in the electrical recording of the heart (electrocardiogram or ECG)
if you have a salt imbalance in the blood, especially low concentrations of potassium in the blood (hypokalaemia) which are currently not corrected by treatment
if you have a very slow heart rate (bradycardia)
if you have a heart failure
if you have a history of abnormal heart rhythms (arrhythmias)
if you are taking other medicines that may affect your heart (see section 2 Other medicines and Fareston).
This is because Fareston can affect your heart by delaying the conduction of electrical signals within your heart (prolongation of QT-interval).
Talk to your doctor or pharmacist before taking Fareston:
if you have unstable diabetes
if your general well-being is severely deteriorated
18
DNO 090017ff8067d83a / 27.3 Confidential In-Progress 18 / 23
DNO 090017ff8067d83a / 27.3 Confidential Reviewed 18 / 23
if you have previously had a condition in which blood clots formed in blood vessels, for example in your lungs (lung embolism) or in the veins of your legs (deep vein thrombosis).
if you experience an abnormal heart rhythm whilst taking Fareston. Your doctor may advise
you to stop taking Fareston and perform a medical test to see how your heart is working (ECG). (see section 2 Do not take Fareston)
if you have any heart condition, including chest pain (angina)
if your cancer has spread to the bones (bone metastasis) as calcium blood levels may increase at the beginning of treatment with Fareston. Your doctor will conduct regular medical check-ups.
if you have been told by your doctor that you have an intolerance to certain sugars, like lactose (see section 2 Fareston contains lactose).
You should have gynaecological examinations before you start treatment with Fareston and at least once a year following the start of treatment with Fareston. Your doctor will conduct regular medical check-ups if you have high blood pressure, diabetes, have taken hormone replacement therapy or if you are obese (BMI over 30).
Tell your doctor if you are taking, have recently taken or might take any other medicines. The dose of some of these may have to be adjusted while you are on Fareston. In particular please tell your doctor if you are taking any of the following:
water tablets (diuretics of thiazide type)
medicines to prevent blood clotting such as warfarin
medicines used to treat epilepsy such as carbamazepine, phenytoin, phenobarbital
medicines used to treat fungal infections such as ketoconazole, itraconazole, voriconazole, posaconazole
medicines used to treat bacterial infections (antibiotics) such as erythromycin, clarithromycin and telithromycin
medicines used to treat viral infection such as ritonavir and nelfinavir.
Do not take Fareston together with the following medicines as there is an increased risk that your heartbeat may be altered (see section 2 Do not take Fareston):
medicines used to treat abnormal heart rhythm (antiarrhythmics); such as quinidine, hydroquinidine, disopyramide, amiodarone, sotalol, dofetilide and ibutilide
medicines used to treat mental and behavioral disorders (neuroleptics); such as phenothiazines, pimozide, sertindole, haloperidol and sultopride
medicines used to treat infections (antimicrobials); such as moxifloxacin, erythromycin (infusion) pentamidine and antimalarials (particularly halofantrine)
certain medicines to treat allergies; such as terfenadine, astemizole and mizolastine
others; cisapride, intravenous vincamine, bepridil, diphemanil.
If you are admitted to the hospital or if you are prescribed a new medicine, please tell your doctor that you are taking Fareston.
Do not use Fareston during pregnancy or breast feeding.
Fareston has no influence on the ability to drive and use machines.
Fareston contains 28.5 mg lactose (as monohydrate) per tablet. If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking this medicinal product.
19
DNO 090017ff8067d83a / 27.3 Confidential In-Progress 19 / 23
DNO 090017ff8067d83a / 27.3 Confidential Reviewed 19 / 23
This medicine contains less than 1 mmol (23 mg) sodium per tablet that is to say essentially ‘sodium- free’.
Always take this medicine exactly as your doctor has told you. Check with your doctor or pharmacist if you are not sure. The usual dose is one 60 mg tablet taken orally, once daily. Fareston can be taken with or without food.
Contact your doctor, pharmacist or the nearest hospital immediately. Symptoms of overdose may be dizziness and headache.
If you miss one dose take the next tablet as usual and continue treatment as recommended. Do not take a double dose to make up for a forgotten tablet. If you have missed several doses, please inform your doctor and follow his instructions.
The treatment with Fareston should only be stopped when advised by your doctor.
If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them. Verycommonsideeffects(may affect more than 1 in 10 people ):
hot flushes, sweating.
Commonsideeffects(may affect up to 1 in 10 people ):
fatigue, dizziness, depression
nausea (feeling sick), vomiting
rash, itching, oedema (swelling)
uterine bleeding, white discharge.
Uncommonsideeffects(may affect up to 1 in 100 people):
headache, sleep disorders
weight increase, constipation, loss of appetite
thickening of the lining of the womb (endometrial hypertrophy)
blood clot for example in the lung (thromboembolic events)
shortness of breath.
Raresideeffects(may affect up to 1 in 1,000 people):
a feeling of spinning (vertigo)
growth on the lining of the womb (endometrial polyps)
increase in liver enzymes (increase of liver transaminases).
Veryraresideeffects(may affect up to 1 in 10,000 people):
changes in the lining of the uterus (endometrium), cancer of the lining of the womb (endometrial cancer)
hair loss (alopecia)
cloudiness of the eye surface (transient corneal opacity)
yellowing of the skin or whites of the eyes (jaundice).
Frequencynotknown (cannot be estimated from the available data):
low number of white blood cells, which are important in fighting infection (leukopenia)
20
DNO 090017ff8067d83a / 27.3 Confidential In-Progress 20 / 23
DNO 090017ff8067d83a / 27.3 Confidential Reviewed 20 / 23
low number of red blood cells (anaemia)
low number of platelets (thrombocytopenia)
inflammation of the liver (hepatitis).
Youshouldcontactyourdoctorimmediatelyifyounoticeanyofthefollowing:
swelling or tenderness in your calf
unexplained shortness of breath or sudden chest pain
vaginal bleeding or changes in vaginal discharge.
Fareston causes certain abnormal changes in the electrical recording of the heart (electrocardiogram or ECG). See section 2 Warnings and precautions.
If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via thenationalreportingsystem listed in Appendix V. By reporting side effects you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the label. The expiry date refers to the last day of that month.
This medicine does not require any special storage conditions.
Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.
The active substance is toremifene; each tablet contains 60 mg (as citrate).
The other ingredients are maize starch, lactose monohydrate, povidone, sodium starch glycolate, microcrystalline cellulose, colloidal anhydrous silica and magnesium stearate.
White, round, flat, bevelled edge tablet with TO 60 on one side. 30 and 100 tablets. Not all pack sizes may be marketed.
Orion Corporation Orionintie 1
FI-02200 Espoo Finland
Orion Corporation Orion Pharma Joensuunkatu 7
FI-24100 Salo
Finland
21
DNO 090017ff8067d83a / 27.3 Confidential In-Progress 21 / 23
DNO 090017ff8067d83a / 27.3 Confidential Reviewed 21 / 23
For any information about this human medicinal product, please contact the local representative of the marketing authorisation holder.
Orion Corporation Tel: +358 10 4261
Orion Pharma Poland Sp. z o.o. Tel: + 48 22 8 333 177
Orion Corporation Tél/Tel: +358 10 4261
Orion Corporation Tlf: +358 10 4261
Orion Corporation Tel: +358 10 4261
Orion Corporation Tel: +358 10 4261
Orion Corporation Tel: +358 10 4261
Orion Corporation Tlf: +358 10 4261
Orion Corporation Τηλ: +358 10 4261
Orion Corporation Tel: +358 10 4261
Orion Corporation Tel: +358 10 4261
Orion Corporation Tlf: +358 10 4261
Orion Pharma
Tél: +33 (0) 1 85 18 00 00
Orion Corporation Tel: +358 10 4261
Orion Corporation Tel.: +358 10 4261
Orion Pharma Poland Sp. z o.o. Tel: + 48 22 8 333 177
Orion Corporation Tlf: +358 10 4261
Orion Corporation Tel: +358 10 4261
Orion Corporation Sími: +358 10 4261
22
DNO 090017ff8067d83a / 27.3 Confidential In-Progress 22 / 23
DNO 090017ff8067d83a / 27.3 Confidential Reviewed 22 / 23
Orion Pharma S.r.l. Tel: + 39 02 67876111
Orion Corporation Puh./Tel: +358 10 4261
Orion Corporation Τηλ: +358 10 4261
Orion Pharma AB Tel: +46 8 623 6440
Orion Corporation Tel: +358 10 4261
Orion Corporation Tel: +358 10 4261
23
DNO 090017ff8067d83a / 27.3 Confidential In-Progress 23 / 23
DNO 090017ff8067d83a / 27.3 Confidential Reviewed 23 / 23